Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1987-7-21
|
| pubmed:abstractText |
Antitumor activity of four modified on amino sugar moiety derivatives of daunorubicin was compared with activity of two commercial preparations of the parental drug in tests against P 388 leukemia in mice. Tested analogs appeared to be similarly effective as the reference drugs, but two of them, DR-2 and DR-19, were found to be significantly less potent.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0004-069X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
34
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
259-62
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3592929-Animals,
pubmed-meshheading:3592929-Daunorubicin,
pubmed-meshheading:3592929-Drug Resistance,
pubmed-meshheading:3592929-Leukemia, Experimental,
pubmed-meshheading:3592929-Leukemia P388,
pubmed-meshheading:3592929-Mice,
pubmed-meshheading:3592929-Structure-Activity Relationship
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|